You should not use this medicine if you are allergic to estradiol, or if you have:unusual vaginal bleeding that has not been checked by a doctor; liver disease; a history of heart attack, stroke, or blood clot; an increased risk of having blood clots due to a heart problem or a ...
Using estradiol can increase your risk of blood clots, stroke, or heart attack, or cancer of the breast, uterus, or ovaries.Estradiol should not be used to prevent heart disease, stroke, ordementia. Have regular physical exams and mammograms, and self-examine your breasts for lumps on a mon...
Two oral contraceptive drugs, Formulation A and Formulation B, both of similar hormonal content, were compared with each other to determine if they were bioequivalent. Both drugs contain l mg of norethindrone (NET) and 0.035 mg of ethinyl estradiol (EE). Application of an interval test for ...
In this work, poly-L-lysine (PLL) grafted by cholate pendants as the only hydrophobic moiety were synthesized in order to facilitate the solubilisation of sterol drugs. Results showed that micelles formed by cholate grafted PLL encapsulated significantly higher level of prednisolone and estradiol than...
treatment. Women switched from conjugated estrogens 0.625 mg/day plus sequential norgestrel 150 jug/day to oral estradiol 2 mg/day plus sequential dydrogesterone 10 mg/day had further increases in BMD, but there was no control group to indicate whether a similar increase would have occurred if ...
PPARalpha-dependent induction of liver microsomal esterification of estradiol and testosterone by a prototypical peroxisome proliferator Endocrinology 2001 142: 3554–3557 CAS PubMed Google Scholar Jackson G . Simvastatin and impotence Br Med J 1997 315: 31–32 Google Scholar Kostis JB, Rosen RC,...
Osteonecrosis of the femoral head (ONFH) is a multifactorial disease leading to severely limited function. By far, the etiology and pathogenesis of ONFH are not fully understood, and surgery is the only effective way to treat ONFH. This study aims to ide
or CYP2C9 substrates may decrease plasma concentration of these drugs and close monitoring is required. As the hormonal contraceptive components progestin and ethinyl estradiol are CYP3A4 substrates, alternative contraceptive methods are required during concomitant use and for 4 months after the last m...
Estradiol 12.5 ± 3.5 Sorafenib -0.4 ± 1.9 Ethinyl estradiol 4.1 ± 1.5 Sulfasalazine 1.0 ± 0.5 Everolimus 2.2 ± 1.1 Sunitinib malate 8.0 ± 0.8 Felodipine 2.4 ± 1.3 Tacrolimus 3.6 ± 0.6 Fenofibrate 16.7 ± 1.2 Telmisartan 14.5 ± 4.3 Flutamide 10.7 ± 1.6 Temsirolimus 1.3 ± 0.4 Fluvasta...
17-.beta.-estradiol, ethinyl estradiol, ethinyl estradiol 3-methyl ether, prednisolone, 17-.beta.-hydroxyprogesterone acetate, 19-nor-progesterone, norgestrel, norethindrone, norethisterone, norethiederone, progesterone, norgesterone, norethynodrel, indomethacin, naproxen, fenoprofen, sulindac, indoprofen...